フローサイトメトリー市場 : 2027年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2022年8月

フローサイトメトリー市場 : 技術 (細胞ベース、ビーズベース)、製品とサービス (分析装置、ソーター、消耗品、ソフトウェア)、用途 [(研究 – 免疫学、幹細胞)、(臨床 – 血液学)]、エンドユーザー (バイオテクノロジー、病院) – 2027年までの世界予測
Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research – Immunology, Stem cell), (Clinical – Hematology)), End user (Biotech, Hospitals) – Global Forecast to 2027

ページ数 319
図表数 369
種別 英文調査報告書
価格 こちらをご覧ください

レポート目次    お問合せ・ご注文    価格・納期について

無料サンプル

The global flow cytometry market is projected to reach USD 6.9 billion by 2027 from USD 4.7 billion in 2022, at a CAGR of 8.1% during the forecast period. Rising prevalence of HIV/AIDS, cancer & autoimmune diseases across the globe is increasing adoption of flow cytometry for diagnosis hence projecting the market growth. Additionally, launch of technologically advent product is furthermore likely to propel the market growth during the forecast period of 2022-2027.

Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research - Immunology, Stem cell), (Clinical - Hematology)), End user (Biotech, Hospitals) - Global Forecast to 2027

“Instruments segment held a substantial share in the global flow cytometry market in 2021.”

Based on product & services, the market is segmented into reagents & consumables, instruments, services, software and accessories. The reagents & consumables segment held a dominant share in the market in 2021 and anticipated to continue dominance during the forecast period. Launch of new reagents & consumables in the market which are making research to grow at faster pace is likely to drive segmental growth. In November 2021, Bio-Rad Laboratories, Inc. (US), launched StarBright UltraViolet 400 Dye, fluorescent nanoparticles designed for use with a UV laser in flow cytometry applications.

“Research applications segment dominated the market in 2021.”

Based on end user, the flow cytometry market is segmented into research applications, clinical applications, and industrial applications. Strong focus of key market players in the clinical applications of flow cytometry is likely to project the segmental growth. For isnatnce, in October 2021, BD (Becton, Dickinson and Company)(US), in collaboration with Christian Medical College Vellore (India) launched its second Center of Excellence (CoE) in flow cytometry for clinical research in India.

“North America held dominant share in 2021.”
Geographically, the flow cytometry market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2021, North America accounted for the major share in the flow cytometry market. North America held dominant share owing to presence of key market players coupled with increased adoption of flow cytometry in research application in the region. Asia Pacific is expected to grow at faster pace due to increased research funding and adoption of flow cytometry in clinical applications.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Supply Side: 70.0%, Demand Side: 30.0%
• By Designation – Managers: 45.0%, CXOs & Directors:30.0%, Excecutives:25.0%
• By Region – North America: 20%, Europe: 10%, Asia Pacific: 55%, Latin America: 10%, and the Middle East and Africa: 5%
List of Companies Profiled in the Report
o Becton, Dickinson and Company (US)
o Danaher Corporation (US)
o Thermo Fisher Scientific, Inc. (US)
o Luminex Corporation (US)
o Agilent Technologies, Inc. (US)
o Sony Group Corporation (Japan)
o Bio-Rad Laboratories, Inc. (US)
o Miltenyi Biotec GmbH (Germany)
o Enzo Biochem, Inc. (US)
o Sysmex Corporation (Japan)
o bioMérieux S.A. (France)
o Cytonome/ST, LLC (US)
o Sartorius AG (Germany)
o Cytek Biosciences, Inc. (US)
o Union Biometrica, Inc. (US)
o Apogee Flow Systems Ltd. (UK)
o Stratedigm, Inc. (US)
o NanoCellect Biomedical, Inc. (US)
o On-chip Biotechnologies, Co., Ltd. (Japan)
o BennuBio Inc. (US)
o ORFLO Technologies (US)
o Bay Biosciences Co., Ltd. (Japan)
o BioLegend, Inc. (US)
o CytoBuoy B.V (Netherlands).

Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research - Immunology, Stem cell), (Clinical - Hematology)), End user (Biotech, Hospitals) - Global Forecast to 2027
Research Coverage:
This report provides a detailed picture of the global flow cytometry market. It aims at estimating the size and future growth potential of the market across different segments, such as technology, product & services, application, end user and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total flow cytometry market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on cell analysis offered by the top 25 players in the flow cytometry market. The report analyses the flow cytometry market by technology, product & services, application, end user and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various flow cytometry products across key geographic regions.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the flow cytometry market.

• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the flow cytometry market.


目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 43)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. – 48)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021)
FIGURE 4 AVERAGE MARKET SIZE ESTIMATION (2021)
2.3 DATA TRIANGULATION APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
2.4 GROWTH FORECAST
2.5 LIMITATIONS
2.6 RISK ASSESSMENT
2.7 CAGR PROJECTIONS
2.7.1 SUPPLY-SIDE ANALYSIS
2.7.2 DEMAND-SIDE ANALYSIS
2.7.3 INSIGHTS FROM PRIMARY EXPERTS

3 EXECUTIVE SUMMARY (Page No. – 58)
FIGURE 6 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2022 VS. 2027 (USD MILLION)
FIGURE 7 FLOW CYTOMETRY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 8 FLOW CYTOMETRY MARKET, BY END USER, 2021
FIGURE 9 GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS (Page No. – 61)
4.1 FLOW CYTOMETRY MARKET OVERVIEW
FIGURE 10 INCREASING PREVALENCE OF AUTOIMMUNE DISEASES AND RISING ADVANCEMENTS IN FLOW CYTOMETRY TECHNIQUES DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: FLOW CYTOMETRY MARKET SHARE, BY PRODUCT & SERVICE (2021)
FIGURE 11 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST  SHARE IN 2021
4.3 FLOW CYTOMETRY MARKET SHARE, BY TECHNOLOGY,  2022 VS. 2027
FIGURE 12 CELL-BASED FLOW CYTOMETRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 FLOW CYTOMETRY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 13 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. – 65)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 14 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,  AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing incidence of HIV/AIDS and cancer
TABLE 1 INCIDENCE OF HIV/AIDS, BY REGION, 2020
TABLE 2 CANCER INCIDENCE, 2020 VS. 2040
5.2.1.2 Flow cytometry techniques in research activities
5.2.1.3 Use of flow cytometry in regenerative medicine
5.2.1.4 Growing public−private initiatives in immunology and immuno-oncology research
5.2.1.5 Technological advancements in flow cytometry instruments
TABLE 3 IMPORTANT TECHNOLOGICAL ADVANCEMENTS (2019–2022)
5.2.2 RESTRAINTS
5.2.2.1 High product cost
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Public-private funding initiatives in stem cell research
TABLE 4 NIH-ESTIMATED STEM CELL RESEARCH EXPENDITURE DATA
5.2.3.3 Adoption of recombinant DNA technology for antibody production
5.2.4 CHALLENGES
5.2.4.1 Complexities related to reagent development
5.2.4.2 Shortage of well-trained and skilled professionals
5.3 PATENT ANALYSIS
5.3.1 LIST OF MAJOR PATENTS
5.4 SUPPLY CHAIN ANALYSIS
FIGURE 15 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES
5.4.1 KEY INFLUENCERS
5.5 VALUE CHAIN ANALYSIS
FIGURE 16 FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
FIGURE 17 FLOW CYTOMETRY MARKET: ECOSYSTEM ANALYSIS
5.6.1 ROLE IN ECOSYSTEM
5.7 REGULATORY ASSESSMENT
5.7.1 STRINGENT FDA REQUIREMENTS
5.7.2 ANALYTE-SPECIFIC REAGENT RULE
5.7.3 LIMITATIONS IN VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS
5.7.4 ABSENCE OF TEST GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS
5.7.5 IVD CE MARK APPROVALS
5.7.6 US: REIMBURSEMENT SCENARIO
5.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 5 FLOW CYTOMETRY MARKET- PORTER’S FIVE FORCES ANALYSIS
5.8.1 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.8.2 BARGAINING POWER OF SUPPLIERS
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 THREAT OF SUBSTITUTES
5.8.5 THREAT OF NEW ENTRANTS
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 18 REVENUE SHIFT & NEW REVENUE POCKETS FOR FLOW CYTOMETRY MARKET
5.10 KEY CONFERENCES & EVENTS IN 2022-2023
TABLE 6 FLOW CYTOMETRY MARKET: DETAILED LIST OF EVENTS AND CONFERENCES
5.11 TRADE DATA
TABLE 7 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017–2021 (USD THOUSAND)
TABLE 8 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017–2021 (USD THOUSAND)
5.12 PRICING ANALYSIS
TABLE 9 COST OF FLOW CYTOMETERS, BY TYPE
TABLE 10 COST OF FLOW CYTOMETERS & OTHER PRODUCTS, BY COMPANY
5.12.1 COST OF FLOW CYTOMETRY SOFTWARE
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
FIGURE 19 KEY STAKEHOLDERS IN PHARMACEUTICAL COMPANIES AND INFLUENCES ON BUYING PROCESSES
FIGURE 20 KEY BUYING CRITERIA FOR FLOW CYTOMETRY PRODUCTS AMONG END USERS

6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY (Page No. – 89)
6.1 INTRODUCTION
TABLE 11 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
6.2 CELL-BASED FLOW CYTOMETRY
6.2.1 RISING R&D INVESTMENTS FOR NEW THERAPEUTIC AGENTS TO DRIVE MARKET GROWTH
TABLE 12 CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 BEAD-BASED FLOW CYTOMETRY
6.3.1 HIGH RELIABILITY AND MEASUREMENT CONSISTENCIES OF BEAD-BASED FLOW CYTOMETRY TO SUPPORT GROWTH
TABLE 13 BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2020–2027 (USD MILLION)

7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE (Page No. – 93)
7.1 INTRODUCTION
TABLE 14 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
7.2 REAGENTS & CONSUMABLES
7.2.1 INCREASING INVESTMENTS IN RESEARCH TO DRIVE MARKET DEMAND
TABLE 15 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET, BY REGION,  2020–2027 (USD MILLION)
7.3 INSTRUMENTS
7.3.1 LAUNCH OF TECHNOLOGICALLY ADVANCED INSTRUMENTS TO PROPEL MARKET GROWTH
TABLE 16 FLOW CYTOMETRY INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 17 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
7.3.2 CELL ANALYZERS
7.3.2.1 Investments by leading market players in developing cell analyzers to drive market growth
TABLE 18 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY REGION,  2020–2027 (USD MILLION)
TABLE 19 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY PRICE RANGE,  2020–2027 (USD MILLION)
7.3.2.2 High-range cell analyzers
7.3.2.2.1 Wide adoption of high-range cell analyzers among end users to drive market growth
TABLE 20 HIGH-RANGE CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3.2.3 Mid-range cell analyzers
7.3.2.3.1 Availability of compact & high-performance analyzers to support market growth
TABLE 21 MID-RANGE CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3.2.4 Low-range cell analyzers
7.3.2.4.1 Low-range analyzers significantly adopted among price-sensitive end users
TABLE 22 LOW-RANGE CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3.3 CELL SORTERS
TABLE 23 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY REGION,  2020–2027 (USD MILLION)
TABLE 24 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY PRICE RANGE,  2020–2027 (USD MILLION)
7.3.3.1 High-range cell sorters
7.3.3.1.1 High cost and budgetary limitations to restrain market growth
TABLE 25 HIGH-RANGE CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3.3.2 Mid-range cell sorters
7.3.3.2.1 Cost-efficiency & frequent product launches for mid-range sorters to drive market growth
TABLE 26 MID-RANGE CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3.3.3 Low-range cell sorters
7.3.3.3.1 Small-scale labs and research facilities to be major end users of low-range sorters
TABLE 27 LOW-RANGE CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.4 SERVICES
7.4.1 FLOW CYTOMETRY SERVICES TO ENSURE WORKFLOW CONTINUITY AND MAXIMIZE PERFORMANCE
TABLE 28 FLOW CYTOMETRY SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
7.5 SOFTWARE
7.5.1 TECHNOLOGICAL ADVANCEMENTS IN SOFTWARE TO DRIVE MARKET GROWTH
TABLE 29 FLOW CYTOMETRY SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
7.6 ACCESSORIES
7.6.1 PROCEDURAL BENEFITS OFFERED BY FLOW CYTOMETRY ACCESSORIES TO SUPPORT MARKET GROWTH
TABLE 30 FLOW CYTOMETRY ACCESSORIES MARKET, BY REGION, 2020–2027 (USD MILLION)

8 FLOW CYTOMETRY MARKET, BY APPLICATION (Page No. – 106)
8.1 INTRODUCTION
TABLE 31 FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
8.2 RESEARCH APPLICATIONS
TABLE 32 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
TABLE 33 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION,  2020–2027 (USD MILLION)
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY
TABLE 34 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE,  2020–2027 (USD MILLION)
8.2.1.1 Drug discovery
8.2.1.1.1 Growing use of phenotypic cell-based assays in drug discovery to support market growth
TABLE 35 FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY REGION,  2020–2027 (USD MILLION)
8.2.1.2 Stem cell research
8.2.1.2.1 Increasing investments in stem cell research to drive demand for flow cytometry products
TABLE 36 FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY REGION,  2020–2027 (USD MILLION)
8.2.1.3 In vitro toxicity testing
8.2.1.3.1 Growing adoption of flow cytometry in drug discovery & development to support market growth
TABLE 37 FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY REGION,  2020–2027 (USD MILLION)
8.2.2 IMMUNOLOGY
8.2.2.1 Growing prevalence of infectious & autoimmune diseases to support market growth
TABLE 38 FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY REGION, 2020–2027 (USD MILLION)
8.2.3 CELL SORTING
8.2.3.1 Technologically advanced cell sorters to drive market growth
TABLE 39 FLOW CYTOMETRY MARKET FOR CELL SORTING, BY REGION, 2020–2027 (USD MILLION)
8.2.4 APOPTOSIS
8.2.4.1 Growing use of apoptosis assays to support market growth
TABLE 40 FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY REGION, 2020–2027 (USD MILLION)
8.2.5 CELL CYCLE ANALYSIS
8.2.5.1 Use of flowcytometry to detect chromosomal abnormalities
TABLE 41 FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY REGION,  2020–2027 (USD MILLION)
8.2.6 CELL VIABILITY
8.2.6.1 Growing use of cell viability assays in research to support market growth
TABLE 42 FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY REGION, 2020–2027 (USD MILLION)
8.2.7 CELL COUNTING
8.2.7.1 Flow cytometry permits easy differentiation of cells via scattering or staining
TABLE 43 FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY REGION,  2020–2027 (USD MILLION)
8.2.8 OTHER RESEARCH APPLICATIONS
TABLE 44 FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION,  2020–2027 (USD MILLION)
8.3 CLINICAL APPLICATIONS
TABLE 45 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
TABLE 46 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION,  2020–2027 (USD MILLION)
8.3.1 CANCER
8.3.1.1 Growing use of flow cytometry techniques in cancer predictions to drive market growth
TABLE 47 ESTIMATED NUMBER OF NEW CANCER CASES (2020–2040)
TABLE 48 FLOW CYTOMETRY MARKET FOR CANCER, BY REGION, 2020–2027 (USD MILLION)
8.3.2 HEMATOLOGY
8.3.2.1 Increasing use of flow cytometry in hematology applications to drive market growth
TABLE 49 FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY REGION, 2020–2027 (USD MILLION)
8.4 IMMUNODEFICIENCY DISEASES
8.4.1 BENEFITS OF FLOW CYTOMETRY IN DIAGNOSIS OF IMMUNODEFICIENCY DISEASES TO DRIVE MARKET GROWTH
TABLE 50 APPLICATION OF FLOW CYTOMETRY IN DIAGNOSIS OF PRIMARY IMMUNODEFICIENCY DISEASES.
TABLE 51 FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASE, BY REGION,  2020–2027 (USD MILLION)
8.4.2 ORGAN & TISSUE TRANSPLANTATION
8.4.2.1 Increasing organ transplants worldwide to drive market growth
TABLE 52 FLOW CYTOMETRY MARKET FOR ORGAN TRANSPLANTATION, BY REGION,  2020–2027 (USD MILLION)
8.4.3 OTHER CLINICAL APPLICATIONS
TABLE 53 FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION,  2020–2027 (USD MILLION)
8.5 INDUSTRIAL APPLICATIONS
8.5.1 GROWING USE OF FLOW CYTOMETRY TECHNIQUES IN FOOD & DIARY TO SUPPORT MARKET GROWTH
TABLE 54 FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION,  2020–2027 (USD MILLION)

9 FLOW CYTOMETRY MARKET, BY END USER (Page No. – 126)
9.1 INTRODUCTION
TABLE 55 FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 ACADEMIC & RESEARCH INSTITUTES
9.2.1 GROWING COLLABORATIONS AMONG ACADEMIC & RESEARCH INSTITUTES EXPECTED TO DRIVE MARKET
TABLE 56 FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION,  2020–2027 (USD MILLION)
9.3 HOSPITALS & CLINICAL TESTING LABORATORIES
9.3.1 USE OF FLOW CYTOMETRY TECHNIQUES IN INFECTIOUS DISEASE DIAGNOSTICS TO DRIVE MARKET GROWTH
TABLE 57 FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES,  BY REGION, 2020–2027 (USD MILLION)
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.4.1 INCREASING INVESTMENTS IN DRUG DISCOVERY & DEVELOPMENT TO SUPPORT MARKET GROWTH
TABLE 58 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,  BY REGION, 2020–2027 (USD MILLION)

10 FLOW CYTOMETRY MARKET, BY REGION (Page No. – 131)
10.1 INTRODUCTION
TABLE 59 FLOW CYTOMETRY MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT
TABLE 60 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 61 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 62 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 63 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 64 NORTH AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 65 NORTH AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 66 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
TABLE 67 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 68 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 69 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 70 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 High incidence of cancer and HIV-AIDS to drive market growth
TABLE 71 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 72 US: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 73 US: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 US: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 75 US: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 76 US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 77 US: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 78 US: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 79 US: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION)
TABLE 80 US: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Ongoing government initiatives for life science research to drive demand
TABLE 81 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 82 CANADA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 83 CANADA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 84 CANADA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 85 CANADA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 86 CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 87 CANADA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 88 CANADA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 89 CANADA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 90 CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 91 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 92 EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 93 EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 94 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 95 EUROPE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 96 EUROPE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 97 EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 98 EUROPE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 99 EUROPE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 100 EUROPE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 101 EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Strong research & development infrastructure and awareness programs on flow cytometry to ensure market growth
TABLE 102 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 103 GERMANY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 104 GERMANY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 105 GERMANY: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 106 GERMANY: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 107 GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 108 GERMANY: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 109 GERMANY: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 110 GERMANY: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 111 GERMANY: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 Acceptance of flow cytometry products for clinical applications to propel market growth
TABLE 112 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 113 UK: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 114 UK: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 UK: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 UK: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 118 UK: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 119 UK: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 120 UK: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION)
TABLE 121 UK: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Strong government funding for proteomics & genomics research to drive market growth
TABLE 122 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 123 FRANCE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 124 FRANCE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 125 FRANCE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 126 FRANCE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 127 FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 128 FRANCE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 129 FRANCE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 130 FRANCE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 131 FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Rising geriatric population and increasing activities in life science to drive market growth
TABLE 132 ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 133 ITALY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 134 ITALY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 135 ITALY: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 ITALY: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 ITALY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 138 ITALY: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 139 ITALY: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 140 ITALY: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 141 ITALY: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing focus on cancer diagnosis to drive demand
TABLE 142 SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 143 SPAIN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 144 SPAIN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 SPAIN: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 146 SPAIN: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 SPAIN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 148 SPAIN: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 149 SPAIN: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 150 SPAIN: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 151 SPAIN: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE (ROE)
TABLE 152 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 153 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 154 REST OF EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 155 REST OF EUROPE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 156 REST OF EUROPE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 157 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
TABLE 158 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 159 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 160 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 161 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: FLOW CYTOMETRY MARKET SNAPSHOT
TABLE 162 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 163 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 164 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 165 ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 166 ASIA PACIFIC: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 167 ASIA PACIFIC: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 168 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 169 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 170 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 171 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 172 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Increasing research on flow cytometry-based techniques to drive market growth
TABLE 173 JAPAN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 174 JAPAN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 175 JAPAN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 176 JAPAN: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 177 JAPAN: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 JAPAN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 179 JAPAN: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 180 JAPAN: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 181 JAPAN: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 182 JAPAN: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 High incidence of target diseases and growing presence of global players to drive market growth
TABLE 183 CHINA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 184 CHINA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 185 CHINA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 186 CHINA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 187 CHINA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 188 CHINA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 189 CHINA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 190 CHINA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 191 CHINA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 192 CHINA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Rising government funding for research activities in proteomics technologies to drive market growth
TABLE 193 INDIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 194 INDIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 195 INDIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 196 INDIA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 197 INDIA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 198 INDIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 199 INDIA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 200 INDIA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 201 INDIA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 202 INDIA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Uptake of flow cytometry techniques to conduct cancer-related research to support market growth
TABLE 203 AUSTRALIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 204 AUSTRALIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 205 AUSTRALIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 206 AUSTRALIA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 207 AUSTRALIA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 208 AUSTRALIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 209 AUSTRALIA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 210 AUSTRALIA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 211 AUSTRALIA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 212 AUSTRALIA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Increasing awareness initiatives on flow cytometry to support market growth
TABLE 213 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 214 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 215 SOUTH KOREA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 216 SOUTH KOREA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 217 SOUTH KOREA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 218 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 219 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 220 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 221 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 222 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.6 SINGAPORE
10.4.6.1 Launch of novel technologies for flow cytometry research to support market growth
TABLE 223 SINGAPORE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 224 SINGAPORE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 225 SINGAPORE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 226 SINGAPORE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 227 SINGAPORE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 228 SINGAPORE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 229 SINGAPORE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 230 SINGAPORE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 231 SINGAPORE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 232 SINGAPORE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.7 INDONESIA
10.4.7.1 Rising prevalence of HIV and cancer to drive demand
TABLE 233 INDONESIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 234 INDONESIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 235 INDONESIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 236 INDONESIA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 237 INDONESIA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 238 INDONESIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 239 INDONESIA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 240 INDONESIA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 241 INDONESIA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 242 INDONESIA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.8 REST OF ASIA PACIFIC (ROAPAC)
TABLE 243 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 244 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 245 REST OF ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 246 REST OF ASIA PACIFIC: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 247 REST OF ASIA PACIFIC: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 248 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
TABLE 249 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 250 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 251 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 252 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER,  2020–2027 (USD MILLION)
10.5 LATIN AMERICA
TABLE 253 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 254 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 255 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 256 LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 257 LATIN AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 258 LATIN AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 259 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
TABLE 260 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 261 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 262 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 263 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Well-established presence of key market players ensures adoption of flow cytometry products
TABLE 264 BRAZIL: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 265 BRAZIL: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 266 BRAZIL: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 267 BRAZIL: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 268 BRAZIL: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 269 BRAZIL: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 270 BRAZIL: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 271 BRAZIL: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 272 BRAZIL: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 273 BRAZIL: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Favorable trade agreements to support availability of flow cytometry products
TABLE 274 MEXICO: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 275 MEXICO: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 276 MEXICO: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 277 MEXICO: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 278 MEXICO: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 279 MEXICO: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 280 MEXICO: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 281 MEXICO: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 282 MEXICO: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 283 MEXICO: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.3 REST OF LATIN AMERICA (ROLATAM)
TABLE 284 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 285 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 286 REST OF LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 287 REST OF LATIN AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 288 REST OF LATIN AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 289 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
TABLE 290 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION)
TABLE 291 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 292 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION)
TABLE 293 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER,  2020–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 GROWING RESEARCH COLLABORATIONS AND RISING FUNDING INITIATIVES TO DRIVE MARKET GROWTH
TABLE 294 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,  2020–2027 (USD MILLION)
TABLE 295 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2020–2027 (USD MILLION)
TABLE 296 MIDDLE EAST & AFRICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 297 MIDDLE EAST & AFRICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 298 MIDDLE EAST & AFRICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE,  2020–2027 (USD MILLION)
TABLE 299 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
TABLE 300 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION)
TABLE 301 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 302 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS,  2020–2027 (USD MILLION)
TABLE 303 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY END USER,  2020–2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. – 251)
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
TABLE 304 FLOW CYTOMETRY MARKET: STRATEGIES ADOPTED
11.3 REVENUE ANALYSIS
FIGURE 23 REVENUE ANALYSIS FOR KEY COMPANIES (2019–2021)
11.4 MARKET SHARE ANALYSIS
FIGURE 24 FLOW CYTOMETRY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
TABLE 305 FLOW CYTOMETRY MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 25 FLOW CYTOMETRY MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
11.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2021)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 26 FLOW CYTOMETRY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR  SMES/START-UPS, 2021
11.7 COMPETITIVE BENCHMARKING
11.7.1 COMPANY FOOTPRINT
TABLE 306 COMPANY PRODUCT FOOTPRINT
TABLE 307 COMPANY REGIONAL FOOTPRINT
11.8 COMPETITIVE SCENARIO AND TRENDS
TABLE 308 FLOW CYTOMETRY MARKET: PRODUCT LAUNCHES & ENHANCEMENTS (JANUARY 2019-JULY 2022)
TABLE 309 FLOW CYTOMETRY MARKET: DEALS, JANUARY 2019–JULY 2022

12 COMPANY PROFILES (Page No. – 264)
(Business overview, Products offered, Recent Developments, MNM view)*
12.1 KEY PLAYERS
12.1.1 BD
TABLE 310 BD: BUSINESS OVERVIEW
FIGURE 27 BD: COMPANY SNAPSHOT (2021)
12.1.2 DANAHER CORPORATION
TABLE 311 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 28 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
12.1.3 THERMO FISHER SCIENTIFIC, INC.
TABLE 312 THERMO FISHER SCIENTIFIC, INC: BUSINESS OVERVIEW
FIGURE 29 THERMO FISHER SCIENTIFIC, INC: COMPANY SNAPSHOT (2021)
12.1.4 AGILENT TECHNOLOGIES, INC
TABLE 313 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 30 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021)
12.1.5 SONY BIOTECHNOLOGY INC. (A SUBSIDIARY OF SONY GROUP CORPORATION)
TABLE 314 SONY GROUP CORPORATION: BUSINESS OVERVIEW
FIGURE 31 SONY GROUP CORPORATION: COMPANY SNAPSHOT (2021)
12.1.6 BIO-RAD LABORATORIES INC.
TABLE 315 BIO-RAD LABORATORIES INC: BUSINESS OVERVIEW
FIGURE 32 BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT (2021)
12.1.7 MILTENYI BIOTEC
TABLE 316 MILTENYI BIOTEC: BUSINESS OVERVIEW
12.1.8 ENZO BIOCHEM, INC.
TABLE 317 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW
FIGURE 33 ENZO BIOCHEM, INC: COMPANY SNAPSHOT (2021)
12.1.9 SYSMEX CORPORATION
TABLE 318 SYSMEX CORPORATION.: BUSINESS OVERVIEW
FIGURE 34 SYSMEX CORPORATION: COMPANY SNAPSHOT (2021)
12.1.10 LUMINEX CORPORATION (A DIASORIN COMPANY)
TABLE 319 DIASORIN S.P.A: BUSINESS OVERVIEW
FIGURE 35 DIASORIN S.P.A: COMPANY SNAPSHOT (2021)
12.1.11 BIOMÉRIEUX SA
TABLE 320 BIOMÉRIEUX SA.: BUSINESS OVERVIEW
FIGURE 36 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2021)
12.1.12 CYTONOME/ST, LLC.
TABLE 321 CYTONOME/ST, LLC: BUSINESS OVERVIEW
12.1.13 SARTORIUS AG
TABLE 322 SARTORIUS AG.: BUSINESS OVERVIEW
FIGURE 37 SARTORIUS AG: COMPANY SNAPSHOT (2021)
TABLE 323 SARTORIUS AG: PRODUCT LAUNCHES
12.1.14 CYTEK BIOSCIENCES
TABLE 324 CYTEK BIOSCIENCES: BUSINESS OVERVIEW
FIGURE 38 CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2021)
12.1.15 UNION BIOMETRICA, INC.
TABLE 325 UNION BIOMETRICA, INC.: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 APOGEE FLOW SYSTEMS LTD.
TABLE 326 APOGEE FLOW SYSTEMS LTD: BUSINESS OVERVIEW
TABLE 327 APOGEE FLOW SYSTEMS: PRODUCTS & SERVICES OFFERED
12.2.2 STRATEDIGM, INC.
TABLE 328 STRATEDIGM, INC: BUSINESS OVERVIEW
TABLE 329 STRATEDIGM, INC: PRODUCT/SERVICE OFFERINGS
TABLE 330 STRATEDIGM: PRODUCT LAUNCHES AND ENHANCEMENTS
TABLE 331 STRATEDIGM, INC: DEALS
12.2.3 NANOCELLECT BIOMEDICAL, INC.
12.2.4 ON-CHIP BIOTECHNOLOGIES CO., LTD.
12.2.5 NEXCELOM BIOSCIENCE LLC.
12.2.6 BENNUBIO INC.
12.2.7 ORFLO TECHNOLOGIES
12.2.8 BAY BIOSCIENCE CO., LTD.
12.2.9 CYTOBUOY B.V.
12.2.10 BIOLEGEND, INC.

*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.

13 APPENDIX (Page No. – 324)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS


    お問合せフォーム

    • レポートのタイトルは自動で入ります。
    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com